Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Alessandra, Anemona"'
Autor:
Odile Launay, David J.M. Lewis, Alessandra Anemona, Pierre Loulergue, Jo Leahy, Antonella Silvia Sciré, Anaïs Maugard, Elisa Marchetti, Stefano Zancan, Zhiming Huo, Simona Rondini, Rachid Marhaba, Oretta Finco, Laura B. Martin, Jochen Auerbach, Daniel Cohen, Allan Saul, Christiane Gerke, Audino Podda
Publikováno v:
EBioMedicine, Vol 22, Iss C, Pp 164-172 (2017)
Background: Approximately 164,000 deaths yearly are due to shigellosis, primarily in developing countries. Thus, a safe and affordable Shigella vaccine is an important public health priority. The GSK Vaccines Institute for Global Health (GVGH) develo
Externí odkaz:
https://doaj.org/article/e7f3d56f66554a5294442f6b34bd8f3a
Autor:
Diego Piccioli, Renzo Alfini, Valentina Monaci, Vanessa Arato, Martina Carducci, Maria Grazia Aruta, Omar Rossi, Francesca Necchi, Alessandra Anemona, Erika Bartolini, Francesca Micoli
Publikováno v:
Vaccine. 40:6305-6314
GMMA has been proposed as a potent technology platform for the design of safe, effective and affordable vaccines. As GMMA are vesicles blebbing out of the outer membrane of Gram-negative bacteria, they contain lipopolysaccharides, lipoproteins and pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b56383ed8e2b1f618e99359ec97c42
https://doi.org/10.1016/j.vaccine.2022.09.034
https://doi.org/10.1016/j.vaccine.2022.09.034
Autor:
Vincent Muturi-Kioi, David Lewis, Odile Launay, Geert Leroux-Roels, Alessandra Anemona, Pierre Loulergue, Caroline L Bodinham, Annelies Aerssens, Nicola Groth, Allan Saul, Audino Podda
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0157385 (2016)
In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported. It is therefore important to evaluate how these trials should be planned not to
Externí odkaz:
https://doaj.org/article/e59188bcc309459f81533ee156dfee72
Autor:
Pierre van Damme, Froukje Kafeja, Alessandra Anemona, Venere Basile, Anne Katrin Hilbert, Ilse De Coster, Simona Rondini, Francesca Micoli, Rana M Qasim Khan, Elisa Marchetti, Vito Di Cioccio, Allan Saul, Laura B Martin, Audino Podda
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e25398 (2011)
Typhoid fever causes more than 21 million cases of disease and 200,000 deaths yearly worldwide, with more than 90% of the disease burden being reported from Asia. Epidemiological data show high disease incidence in young children and suggest that imm
Externí odkaz:
https://doaj.org/article/5f6775f06f2643cda35a3d7d4ec4b6c9
Autor:
Elisa Marchetti, Nelia Malubay, Rana M. Qasim Khan, Shabina Ariff, Maria Rosario Capeding, Rachid Marhaba, Allan Saul, Muhammad Atif Habib, Zulfiqar A Bhutta, Anand Kawade, Audino Podda, Alessandra Anemona, Ashish Bavdekar, Sajid Bashir Soofi, Sanjay Juvekar, Edison Alberto, Noshad Ali, Laura B. Martin
Publikováno v:
The Lancet Infectious Diseases. 14:119-129
Summary Background Typhoid vaccination is a public health priority in developing countries where young children are greatly affected by typhoid fever. Because present vaccines are not recommended for children younger than 2 years, the Novartis Vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5c028ec28cd7d1a5acc33fa1be017d
https://doi.org/10.1016/s1473-3099(13)70241-x
https://doi.org/10.1016/s1473-3099(13)70241-x
Autor:
Alessandra Anemona, Francisco Diaz-Mitoma, Francesca Ceddia, Peter M. Dull, Scott A. Halperin
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 29:259-267
With the emergence of multiple meningococcal serogroups in different geographic areas, broad vaccine protection from infancy is desirable. One hundred and seventy-five infants received either two doses of a meningococcal quadrivalent (A, C, W-135, Y)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6691819ee545444f2e29eef8423f82b3
https://doi.org/10.1007/s10096-009-0848-8
https://doi.org/10.1007/s10096-009-0848-8
Autor:
Keith S. Reisinger, Robert M. Jacobson, Alessandra Anemona, Lisa A. Jackson, Lisa Danzig, Peter M. Dull
Publikováno v:
Pediatric Infectious Disease Journal. 28:86-91
Because of the well-documented increased risk of meningococcal disease among adolescents, vaccination is recommended for this population in many countries, including the United States. This study compared the tolerability and immunogenicity in adoles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289e3fe5fcc19bee0a27a7e23fcdf608
https://doi.org/10.1097/inf.0b013e31818a0237
https://doi.org/10.1097/inf.0b013e31818a0237
Publikováno v:
Statistics in Medicine. 27:3743-3754
For some trials, simple but subtle assumptions can have a profound impact on the size of the trial. A case in point is a vaccine lot consistency (or equivalence) trial. Standard sample size formulas used for designing lot consistency trials rely on o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc92e12ed89c9adee60ea2f7b5a912b0
https://doi.org/10.1002/sim.3273
https://doi.org/10.1002/sim.3273
Autor:
Pierre Loulergue, David F.V. Lewis, Annelies Aerssens, Geert Leroux-Roels, Vincent Muturi-Kioi, Nicola Groth, Alessandra Anemona, Allan Saul, Odile Launay, Caroline L. Bodinham, Audino Podda
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0157385 (2016)
PLOS ONE
PLoS ONE
PLOS ONE
PLoS ONE
Background In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported. It is therefore important to evaluate how these trials should be plan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ee483ba324e2c242faea370019f3210
http://europepmc.org/articles/PMC4974007?pdf=render
http://europepmc.org/articles/PMC4974007?pdf=render
Autor:
John Changalucha, Deborah Watson-Jones, David Ross, Dean Everett, Alessandra Anemona, David Mabey, John Parry, Richard J. Hayes, Helen A. Weiss, Tobias Chirwa
Publikováno v:
Tropical Medicine & International Health. 12:1323-1326
OBJECTIVE To determine the specificity of the Abbott Murex HIV antigen/antibody combination enzyme immunoassay (EIA) for the diagnosis of HIV infection in Tanzania. METHODS A cross-sectional survey of 7333 Tanzanian adolescents and young adults was c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcb89aed2eabb2667cf8f404cde24e01
https://doi.org/10.1111/j.1365-3156.2007.01933.x
https://doi.org/10.1111/j.1365-3156.2007.01933.x